PRLD
Price
$1.03
Change
+$0.05 (+5.10%)
Updated
Jun 6 closing price
Capitalization
58.15M
67 days until earnings call
PRTG
Price
$8.41
Change
+$0.03 (+0.36%)
Updated
Jun 6 closing price
Capitalization
13.84M
Interact to see
Advertisement

PRLD vs PRTG

Header iconPRLD vs PRTG Comparison
Open Charts PRLD vs PRTGBanner chart's image
Prelude Therapeutics
Price$1.03
Change+$0.05 (+5.10%)
Volume$122.56K
Capitalization58.15M
Portage Biotech
Price$8.41
Change+$0.03 (+0.36%)
Volume$12.25K
Capitalization13.84M
PRLD vs PRTG Comparison Chart
Loading...
PRLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRTG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRLD vs. PRTG commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRLD is a Hold and PRTG is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (PRLD: $1.03 vs. PRTG: $8.41)
Brand notoriety: PRLD and PRTG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRLD: 86% vs. PRTG: 1%
Market capitalization -- PRLD: $58.15M vs. PRTG: $13.84M
PRLD [@Biotechnology] is valued at $58.15M. PRTG’s [@Biotechnology] market capitalization is $13.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRLD’s FA Score shows that 1 FA rating(s) are green whilePRTG’s FA Score has 0 green FA rating(s).

  • PRLD’s FA Score: 1 green, 4 red.
  • PRTG’s FA Score: 0 green, 5 red.
According to our system of comparison, PRLD is a better buy in the long-term than PRTG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRLD’s TA Score shows that 5 TA indicator(s) are bullish while PRTG’s TA Score has 5 bullish TA indicator(s).

  • PRLD’s TA Score: 5 bullish, 2 bearish.
  • PRTG’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, PRLD is a better buy in the short-term than PRTG.

Price Growth

PRLD (@Biotechnology) experienced а +16.27% price change this week, while PRTG (@Biotechnology) price change was +4.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

PRLD is expected to report earnings on Aug 13, 2025.

PRTG is expected to report earnings on Aug 26, 2024.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRLD($58.2M) has a higher market cap than PRTG($13.8M). PRTG YTD gains are higher at: 62.669 vs. PRLD (-19.216). PRTG has higher annual earnings (EBITDA): -79.36M vs. PRLD (-138.2M). PRLD has more cash in the bank: 99.1M vs. PRTG (1.76M). PRTG has less debt than PRLD: PRTG (28K) vs PRLD (17.9M). PRLD has higher revenues than PRTG: PRLD (7M) vs PRTG (0).
PRLDPRTGPRLD / PRTG
Capitalization58.2M13.8M422%
EBITDA-138.2M-79.36M174%
Gain YTD-19.21662.669-31%
P/E RatioN/A0.17-
Revenue7M0-
Total Cash99.1M1.76M5,618%
Total Debt17.9M28K63,929%
FUNDAMENTALS RATINGS
PRTG: Fundamental Ratings
PRTG
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
89
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRLDPRTG
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 9 days ago
85%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PRLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRTG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HNST5.160.04
+0.78%
Honest Company (The)
SIGI87.420.04
+0.05%
Selective Insurance Group
BBU25.20-0.03
-0.12%
Brookfield Business Partners LPLimited Partnership Units
MDLZ66.15-0.22
-0.33%
Mondelez International
IFRX0.83-0.02
-2.23%
InflaRx NV

PRLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRLD has been loosely correlated with MGTX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if PRLD jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRLD
1D Price
Change %
PRLD100%
+5.30%
MGTX - PRLD
37%
Loosely correlated
+9.49%
GBIO - PRLD
36%
Loosely correlated
+19.26%
HUMA - PRLD
36%
Loosely correlated
-1.15%
ITOS - PRLD
35%
Loosely correlated
-0.10%
AMRN - PRLD
35%
Loosely correlated
+7.34%
More

PRTG and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRTG has been loosely correlated with AMGXF. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PRTG jumps, then AMGXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTG
1D Price
Change %
PRTG100%
+0.36%
AMGXF - PRTG
34%
Loosely correlated
N/A
NBY - PRTG
34%
Loosely correlated
-1.64%
PRLD - PRTG
27%
Poorly correlated
+5.30%
CVAC - PRTG
26%
Poorly correlated
-1.12%
JSPR - PRTG
26%
Poorly correlated
+5.44%
More